Research On Operation Management Of China Vaccines Cold Chain Logistgics Based On G Company

In recent years, with the rising level of the national economy, people’s consumptionlevel rise and the continuous improvement of quality of life, there have been more andmore people aware of the “prevention” than “cure” to the important. People are willing tospend more time to exercise, appliance manufacturers and restaurants, and even suchpeople think KFC and McDonald’s unhealthy “junk food” also played a “healthy fast food”concept. Visible, people’s health and the growing desire for attention.It is against this backdrop, more and more people realize that "vaccination" is not justthe baby’s patents, people increasingly to enhance the concept of prevention. Forexample, many dog owners would rather take the initiative in order to prevent being bittenby dogs to go injection f rabies vaccine. Therefore, how to make better use of high-qualitypatient pharmaceutical products, the pharmaceutical industry has become a pressing issue.Firstly, from large chain logistics this basic concept to start and then transition to thepharmaceutical cold chain logistics and cold chain logistics, from medicine to the vaccinecold chain logistics cold chain logistics introduced the concept of layers of unravelingthese concepts are given a clear concept. Among them, over-temperature cold chain is abreakthrough in traditional discourse, the introduction of "stability requirements", the newconcept. In the course of discussion, not only introduces the basic status of Chinesevaccine cold chain, but also on the object of this paper G company vaccine cold chainchannels were analyzed, and then leads to the problems encountered by the company, theuse of scientific analysis methods for the analysis of the problem, identify problems, findthe problem, propose solutions, implementation of the program, tracking the results ofimplementation of the program and other relevant aspects of the exposition.In this paper, a vaccine to run a business perspective analysis, aimed at the entirevaccine cold chain logistics system and the whole pharmaceutical cold chain logisticssystem for the development of reference value.